ENTITY

Sichuan Kelun-Biotech Biopharm (6990 HK)

31
Analysis
Health CareChina
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. operates biotechnology businesses. The Company develops and provides biological drugs, chemical raw materials, antibody conjugating drugs, innovative drugs, and other products. Kelun Biotech also operates import and export businesses.
more
21 Aug 2024 18:32Broker

Kelun-Biotech (6990 HK) - Innovative Bispecific ADC Product Licensed to MSD

Kelun-Biotech recorded RMB1.38bn (+32% YoY) revenue in 1H24, including a total of US$90mn (or RMB641mn) milestone payments from MSD regarding...

Logo
157 Views
Share
07 Jun 2024 07:53Broker

Kelun-Biotech (6990 HK) - Data Release at ASCO Further Confirmed SKB264’s Potential

With Trodelvy and Dato-DXd missing the OS endpoints in Ph3 trials for 2/3L NSCLC, we think SKB264 will enjoy a better positioning in the global...

Logo
290 Views
Share
27 Mar 2024 18:46Broker

Kelun-Biotech (6990 HK) - Intense Data Release to Further Validate the Global Potential of SKB264

In Mar 2023, SKB received around RMB1.21bn upfront payment from MSD for out-licensing certain pre-clinical ADC assets, a portion of which was...

Logo
246 Views
Share
19 Mar 2024 09:14Broker

Kelun-Biotech (6990 HK) - MSD Has Further Expedited Global Clinical Development of SKB264

These studies encompass a wide range of NSCLC stages and further probe SKB264's utility in breast and endometrial cancers, highlighting its global...

Logo
208 Views
Share
06 Mar 2024 20:03Broker

Kelun-Biotech (6990 HK) - A Trailblazer in ADC Arena

Leveraging a robust integrated ADC platform, the company has developed several differentiated clinical-stage ADCs - including SKB264 (TROP2 ADC),...

Logo
181 Views
Share
x